Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.

@article{Goadsby2008EarlyVN,
  title={Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.},
  author={Peter J Goadsby and Giorgio Zanchin and Gilles G{\'e}raud and Nina de Klippel and Samuel D{\'i}az-Insa and Heike Gobel and L Cunha and Nathalie Ivanoff and Meritxell Falqu{\'e}s and Josep Fortea},
  journal={Cephalalgia : an international journal of headache},
  year={2008},
  volume={28 4},
  pages={383-91}
}
The study was designed to compare the response to almotriptan in migraine patients who take medication early in the course of the attack with that when medication is taken after pain has become moderate or severe. A randomized, four-arm, multicentre, multinational, double-blind, placebo-controlled trial of almotriptan (12.5 mg) comparing treatment… CONTINUE READING